WHO/FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials

Pyramax is also being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data
Pyramax is also being tried in South Africa, Kenya and Burkina Faso to pick African efficacy data